Story excerpt provided by Dayton Business Journal.
Written by John Bush.
Fueled by new investments and successful clinical trials, a Dayton-area bioscience company is ready to bring its product to market and hire dozens of new employees.
Oxford-based Ischemia Care, which has a clinical laboratory in Middletown, is a molecular diagnostic enterprise that has developed a blood test for timely diagnosis and treatment of strokes. Company founder and CEO Jeff June says the test, called ISCDX, will hit the commercial market within the next 60 days.
Click here to read the complete article.
Originally published March 6, 2018.